Publication:
New 3-Hydroxyquinaldic Acid Derivatives from Cultures of the Marine Derived Actinomycete Streptomyces cyaneofuscatus M-157.

dc.contributor.authorOrtiz-López, Francisco Javier
dc.contributor.authorAlcalde, Elsa
dc.contributor.authorSarmiento-Vizcaíno, Aida
dc.contributor.authorDíaz, Caridad
dc.contributor.authorCautain, Bastien
dc.contributor.authorGarcía, Luis A
dc.contributor.authorBlanco, Gloria
dc.contributor.authorReyes, Fernando
dc.date.accessioned2023-01-25T10:22:57Z
dc.date.available2023-01-25T10:22:57Z
dc.date.issued2018-10-08
dc.description.abstractFractionation of the bioactive extract of a culture of the marine derived actinomycete Streptomyces cyaneofuscatus M-157 led to the isolation of the known 3-hydroxyquinaldic acid (4), its amide (5) and three new derivatives (1⁻3) containing different amino acid residues. The structures of the new molecules (1⁻3), including their absolute configuration, were determined by the analysis of their ESI-TOF MS and one-dimensional (1D) and two-dimensional (2D) NMR spectra and advanced Marfey's analysis of their hydrolyzation products. Compound 3 spontaneously dimerized in solution to give the disulfide derivative 6. Unfortunately, none of the new compounds isolated confirmed the antimicrobial activity found in the bacterial extract, perhaps indicating that such antibacterial activity might be due to presence in the extract at the trace level of larger bioactive 3-hydroxyquinaldic acid derivatives from which compounds 1⁻3 are biosynthetic precursors. Cytotoxicity tests confirmed the moderate and weak IC50 values of 15.6 and 51.5 µM for compounds 5 and 1, respectively.
dc.identifier.doi10.3390/md16100371
dc.identifier.essn1660-3397
dc.identifier.pmcPMC6212950
dc.identifier.pmid30297652
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212950/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/1660-3397/16/10/371/pdf?version=1539152504
dc.identifier.urihttp://hdl.handle.net/10668/13044
dc.issue.number10
dc.journal.titleMarine drugs
dc.journal.titleabbreviationMar Drugs
dc.language.isoen
dc.organizationFundación MEDINA (Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía)
dc.organizationFundación MEDINA
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject3-hydroxyquinaldic acid
dc.subjectCantabrian Sea
dc.subjectStreptomyces cyaneofuscatus
dc.subjectdeep-sea actinobacteria
dc.subject.meshActinobacteria
dc.subject.meshAnti-Bacterial Agents
dc.subject.meshAquatic Organisms
dc.subject.meshKynurenic Acid
dc.subject.meshMagnetic Resonance Spectroscopy
dc.subject.meshMicrobial Sensitivity Tests
dc.subject.meshStreptomyces
dc.titleNew 3-Hydroxyquinaldic Acid Derivatives from Cultures of the Marine Derived Actinomycete Streptomyces cyaneofuscatus M-157.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number16
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6212950.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format